SEC Form 4 filed by Director Ferko William G
4 - SYPRIS SOLUTIONS INC (0000864240) (Issuer)
- SEC Form 424B3 filed by MSP Recovery Inc.
424B3 - MSP Recovery, Inc. (0001802450) (Filer)
- Director Matsumoto Oki was granted 509 shares, increasing direct ownership by 6% to 8,692 units (SEC Form 4)
4 - Mastercard Inc (0001141391) (Issuer)
- Amendment: SEC Form 4 filed by Director Lawrence David F.
4/A - NORTHPOINTE BANCSHARES INC (0001336706) (Issuer)
- SEC Form 4 filed by Director Healey William L
4 - SYPRIS SOLUTIONS INC (0000864240) (Issuer)
- Amendment: SEC Form 4 filed by Director Hood Rodney E.
4/A - NORTHPOINTE BANCSHARES INC (0001336706) (Issuer)
- Director Bhanji Muna was granted 26,455 shares, increasing direct ownership by 19% to 163,808 units (SEC Form 4)
4 - ARDELYX, INC. (0001437402) (Issuer)
- Amendment: SEC Form 4 filed by Director Tuttle John Robert
4/A - NORTHPOINTE BANCSHARES INC (0001336706) (Issuer)
- Director Baker Bros. Advisors Lp was granted 1,816 shares (SEC Form 4)
4 - MADRIGAL PHARMACEUTICALS, INC. (0001157601) (Issuer)
- SEC Form 4 filed by CEO Ulm Scott
4 - Armour Residential REIT, Inc. (0001428205) (Issuer)
- SEC Form 144 filed by Brilliant Earth Group Inc.
144 - Brilliant Earth Group, Inc. (0001866757) (Subject)
- Amendment: SEC Form 4 filed by Director Hooker David Stevens
4/A - NORTHPOINTE BANCSHARES INC (0001336706) (Issuer)
- SEC Form 144 filed by CAVA Group Inc.
144 - CAVA GROUP, INC. (0001639438) (Subject)
- Silvercrest Asset Management Group Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
8-K - Silvercrest Asset Management Group Inc. (0001549966) (Filer)
- Director Hassan Emil E sold $312,561 worth of Shares of Common Stock (1,563 units at $199.97), decreasing direct ownership by 2% to 71,532 units (SEC Form 4)
4 - NATIONAL HEALTHCARE CORP (0001047335) (Issuer)
- Amendment: SEC Form 4 filed by Director De Vlieger Robert W Ii
4/A - NORTHPOINTE BANCSHARES INC (0001336706) (Issuer)
- SEC Form 6-K filed by Alibaba Group Holding Limited
6-K - Alibaba Group Holding Ltd (0001577552) (Filer)
- Zentalis Pharmaceuticals Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
8-K - Zentalis Pharmaceuticals, Inc. (0001725160) (Filer)